Oligodendrogliomas Completed Phase 1 Trials for Motexafin gadolinium (DB05428)
Also known as: Oligodendroglioma of Brain / Oligodendroglioma / Oligodendroglioma - category (morphologic abnormality) / Oligodendroglioma (morphologic abnormality) / [M]Oligodendroglioma NOS (morphologic abnormality)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0032978 (Oligodendrogliomas) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00080054 | A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas | Treatment |